// Post a message

Replying to:

Phase II metronomic Vinblastine for Chemotherapy-Naïve Children With Progressive Low-Grade Glioma

A recent artivle published inthe JCO by Alvaro Lassaletta and al. report on the use of metronomic weekly vinblastine in 54 children with naive LGG.Five-year overall survival and progression-free survival (PFS) rates were 94% and 53% respectively, for the entire cohort with better outcome for NF1 patients. Treatment was well tolerated and quality of life remained stable during treatment. The article entitled : Phase II Weekly Vinblastine for Chemotherapy-Naïve Children With Progressive (...)


This forum is moderated beforehand: your contribution will only appear after being validated by a site administrator.

Any message or comment?
  • (To create paragraphs, you simply leave blank lines.)

Who are you? (optional)